Teiji Wada
Impact in
- Immunology top 1%
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Cancer Research top 1%
- NF-κB Signaling Pathways
Papers in
-
- Melanoma and MAPK Pathways 10
- Receptor Mechanisms and Signaling 4
- Bone Metabolism and Diseases 4
- Cell death mechanisms and regulation 4
- Immunology 10
- Immunotherapy and Immune Responses 4
- Immune Response and Inflammation 4
- Co-authors
- Josef Penninger (29 shared papers)Tomoki Nakashima (4 shared papers)Hiroshi Nishina (10 shared papers)Renu Sarao (7 shared papers)Michael A. Crackower (4 shared papers)Chi-chung Hui (2 shared papers)Stefan Uhlig (1 shared paper)Keiji Kuba (1 shared paper)
In The Last Decade
Teiji Wada
44 papers receiving 9.1k citations
Teiji Wada's Hit Papers
Peers
Comparison fields: 5 of 136
- Immunology 1.8k
- Cancer Research 1.1k
- Oncology 1.8k
- Infectious Diseases 1.2k
- Molecular Biology 4.3k
Countries citing papers authored by Teiji Wada
This map shows the geographic impact of Teiji Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teiji Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teiji Wada more than expected).
Fields of papers citing papers by Teiji Wada
This network shows the impact of papers produced by Teiji Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teiji Wada. The network helps show where Teiji Wada may publish in the future.
Co-authors
The 25 scholars most cited alongside Teiji Wada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Angiotensin-converting enzyme 2 protects from severe acute lung failure Hit paper breakdown → | 2005 | 1833 |
| 2 | Mitogen-activated protein kinases in apoptosis regulation Hit paper breakdown → | 2004 | 1264 |
| 3 | RANKL–RANK signaling in osteoclastogenesis and bone disease Hit paper breakdown → | 2005 | 957 |
| 4 | Electrical signals control wound healing through phosphatidylinositol-3-OH kinase-γ and PTEN Hit paper breakdown → | 2006 | 907 |
| 5 | Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4 Hit paper breakdown → | 2002 | 653 |
| 6 | Regulation of cancer cell migration and bone metastasis by RANKL Hit paper breakdown → | 2006 | 603 |
| 7 | 2003 | 278 | |
| 8 | 2004 | 277 | |
| 9 | 2002 | 221 | |
| 10 | 2018 | 214 | |
| 11 | 2003 | 173 | |
| 12 | 2005 | 160 | |
| 13 | 2005 | 143 | |
| 14 | 2003 | 137 | |
| 15 | 2002 | 123 | |
| 16 | 2004 | 122 | |
| 17 | 2007 | 114 | |
| 18 | 2007 | 113 | |
| 19 | 2002 | 87 | |
| 20 | 2006 | 80 |
About Teiji Wada
Teiji Wada is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Physiology, having authored 45 papers that have together received 9.2k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (10 papers), NF-κB Signaling Pathways (8 papers), Receptor Mechanisms and Signaling (4 papers), Immunotherapy and Immune Responses (4 papers), Bone Metabolism and Diseases (4 papers), Bone health and treatments (4 papers), Immune Response and Inflammation (4 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Immunology (1.8k citations), Cancer Research (1.1k citations), Oncology (1.8k citations), Infectious Diseases (1.2k citations) and Molecular Biology (4.3k citations). Teiji Wada has collaborated with scholars based in Japan, Austria and Canada. Frequent co-authors include Josef Penninger, Tomoki Nakashima, Hiroshi Nishina, Renu Sarao, Michael A. Crackower, Chi-chung Hui, Stefan Uhlig, Keiji Kuba, Yumiko Imai and Lutz Hein. Their work appears in journals such as Nature, Journal of Biological Chemistry, PLoS ONE, The Journal of Experimental Medicine and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.